The Pharmaceutical Contract Management Consulting industry is expected to experience consistent growth over the five years to 2016. Consultants in this industry have benefited particularly from a string of expiration dates for the patents on major medicines, which has driven pharmaceutical companies large and small to management consultants for help formulating new research and development strategies in a rapidly shifting landscape. Healthcare reform has also driven demand for the industry, as drug companies strive to project the potential financial impacts of recent legislation. These trends will largely hold over the five years to 2021, leading pharmaceutical companies to purchase consulting services to understand increasingly complex regulations and supply chains.
This industry provides consulting to pharmaceutical companies, which includes the assessment of cost structures and client contracting processes. Firms ensure compliance and track performance. This can include the development and implementation of software for these purposes.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.